Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT00824837

Study of beta2-Microglobulin Removal by Standard Versus New High Cut-Off Haemodialysis Membrane (HiCOF)

Randomised, Cross Over Pilot Study Comparing Removal of beta2-Microglobulin by Standard Haemodialysis to Haemodialysis With a Novel Dialysis Membrane (P2SH) in Chronic Dialysis Patients

Sponsor: Austin Health

Conditions Renal Dialysis

Interventions Larger pore haemodialysis membrane Standard haemodialysis membrane

Updated 5 times since 2017 Last updated: Jul 6, 2009 Started: Oct 31, 2008 Primary completion: Dec 31, 2008 Completion: Dec 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00824837, this PHASE1/PHASE2 trial focuses on Renal Dialysis and remains completed. Sponsored by Austin Health, it has been updated 5 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Oct 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Austin Health

Data source: Austin Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Melbourne, Australia